CDI Labs
Biotechnology ResearchPuerto Rico, Puerto Rico11-50 Employees
CDI Labs is a biotechnology research company that operates as a contract research organization and lab services provider focused on proteomics, underpinned by synthetic biology platforms. It has built what it describes as the world's largest collection of proteomes and fields a team with extensive proteomics bench expertise to map molecular interactions across entire proteomes. Based in San Germán, Puerto Rico, the company serves clients across basic research, discovery, validation, and clinical deployment phases, offering support from biomarker discovery to target identification and downstream validation. Its service portfolio targets autoantibody biomarker discovery, viral exposure profiling, immunogenicity assessment for cell, gene and radioligand therapies, antibody and ADC specificity profiling, and target identification for monoclonal and biologic drugs, along with custom protein and monoclonal antibody manufacturing for downstream validation. In July 2024 the company announced an expansion of its offerings to provide proteome-wide antibody profiling capabilities, reflecting its ongoing development in the field. The organization serves researchers and developers in the life sciences pursuing proteome-scale insights and translational validation.
1-888-653-2347 
support@leadiq.com 
